Aptorum Group Limited [NASDAQ: APM] stock went on an upward path that rose over 16.14% on Friday, amounting to a one-week price increase of more than 22.59%. The company report on December 21, 2020 that Aptorum Group Announces Submission of Clinical Trial Application for ALS-4, an Orally Administered Small Molecule Drug for the Treatment of Infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA).
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies for the treatment of a variety of medical conditions including infectious diseases, announced that the company, through its wholly owned subsidiary Aptorum International Limited, has submitted a Clinical Trial Application (CTA) with the Public Health Agency of Canada (Health Canada) to conduct a Phase 1 clinical trial of ALS-4, an orally administered small molecule drug for the treatment of infections caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA). Pending Health Canada’s approval, the Phase 1 trial is designed to test the safety, tolerability and pharmacokinetics of ALS-4 in healthy volunteers.
Over the last 12 months, APM stock dropped by -76.47%. The average equity rating for APM stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $96.88 million, with 29.96 million shares outstanding and 8.57 million shares in the current float. Compared to the average trading volume of 295.36K shares, APM stock reached a trading volume of 857580 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Aptorum Group Limited [APM]:
The Average True Range (ATR) for Aptorum Group Limited is set at 0.19, with the Price to Sales ratio for APM stock in the period of the last 12 months amounting to 161.47. The Price to Book ratio for the last quarter was 5.02, with the Price to Cash per share for the same quarter was set at 0.15.
APM Stock Performance Analysis:
Aptorum Group Limited [APM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 22.59. With this latest performance, APM shares gained by 25.38% in over the last four-week period, additionally sinking by -10.54% over the last 6 months – not to mention a drop of -76.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APM stock in for the last two-week period is set at 75.66, with the RSI for the last a single of trading hit 82.53, and the three-weeks RSI is set at 69.49 for Aptorum Group Limited [APM]. The present Moving Average for the last 50 days of trading for this stock 2.49, while it was recorded at 2.90 for the last single week of trading, and 2.90 for the last 200 days.
Insight into Aptorum Group Limited Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Aptorum Group Limited [APM] shares currently have an operating margin of -3400.52 and a Gross Margin at -291.31. Aptorum Group Limited’s Net Margin is presently recorded at -3491.77.
Return on Total Capital for APM is now -56.48, given the latest momentum, and Return on Invested Capital for the company is -66.68. Return on Equity for this stock declined to -75.54, with Return on Assets sitting at -54.14. When it comes to the capital structure of this company, Aptorum Group Limited [APM] has a Total Debt to Total Equity ratio set at 39.83. Additionally, APM Total Debt to Total Capital is recorded at 28.48, with Total Debt to Total Assets ending up at 27.20. Long-Term Debt to Equity for the company is recorded at 39.29, with the Long-Term Debt to Total Capital now at 28.10.
Reflecting on the efficiency of the workforce at the company, Aptorum Group Limited [APM] managed to generate an average of -$505,048 per employee. Receivables Turnover for the company is 0.79 with a Total Asset Turnover recorded at a value of 0.02.Aptorum Group Limited’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.00 and a Current Ratio set at 2.00.
Aptorum Group Limited [APM] Insider Position Details
There are presently around $0 million, or 0.80% of APM stock, in the hands of institutional investors. The top three institutional holders of APM stocks are: CVI HOLDINGS, LLC with ownership of 64,754, which is approximately New of the company’s market cap and around 26.43% of the total institutional ownership; JANE STREET GROUP, LLC, holding 11,074 shares of the stock with an approximate value of $37000.0 in APM stocks shares; and MORGAN STANLEY, currently with $30000.0 in APM stock with ownership of nearly New of the company’s market capitalization.
6 institutional holders increased their position in Aptorum Group Limited [NASDAQ:APM] by around 87,124 shares. Additionally, 1 investors decreased positions by around 12,753 shares, while 0 investors held positions by with 12,753 shares. The mentioned changes placed institutional holdings at 87,124 shares, according to the latest SEC report filing. APM stock had 6 new institutional investments in for a total of 87,124 shares, while 1 institutional investors sold positions of 12,753 shares during the same period.